RIN3 Is a Negative Regulator of Mast Cell Responses to SCF

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Janson, Christine ^a   Kasahara, Noriyuki ^a   Prendergast, George C ^b   Colicelli, John ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; MEMBRANE PROTEIN; PROTEIN BIN2; PROTEIN RIN3; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BIOTINYLATION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENDOCYTOSIS; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTERNALIZATION; MACROPHAGE; MAST CELL; MASTOCYTOSIS; NONHUMAN; OSTEOCLAST; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANTIGENS, CD14; BENZAMIDES; CARRIER PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; ENDOCYTOSIS; GENE EXPRESSION REGULATION; GENE SILENCING; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAST CELLS; MASTOCYTOSIS; PIPERAZINES; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; RAB5 GTP-BINDING PROTEINS; STEM CELL FACTOR;

EID: 84869782913     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049615     Document Type: Article

References (55)

1. Gilfillan AM, Beaven MA, (2011) Regulation of mast cell responses in health and disease. Crit Rev Immunol 31: 475-529.
2. Amin K, (2012) The role of mast cells in allergic inflammation. Respir Med 106: 9-14.
3. Ronnstrand L, (2004) Signal transduction via the stem cell factor receptor/c-Kit. Cell Mol Life Sci 61: 2535-2548.
4. Roskoski R Jr, (2005) Structure and regulation of Kit protein-tyrosine kinase-the stem cell factor receptor. Biochem Biophys Res Commun 338: 1307-1315.
5. Roskoski R Jr, (2005) Signaling by Kit protein-tyrosine kinase-the stem cell factor receptor. Biochem Biophys Res Commun 337: 1-13.
6. Campbell E, Hogaboam C, Lincoln P, Lukacs NW, (1999) Stem cell factor-induced airway hyperreactivity in allergic and normal mice. Am J Pathol 154: 1259-1265.
7. Ashman LK, (1999) The biology of stem cell factor and its receptor C-kit. Int J Biochem Cell Biol 31: 1037-1051.
8. Boissan M, Feger F, Guillosson JJ, Arock M, (2000) c-Kit and c-kit mutations in mastocytosis and other hematological diseases. J Leukoc Biol 67: 135-148.
9. Metcalfe DD, (2008) Mast cells and mastocytosis. Blood 112: 946-956.
10. Qualmann B, Koch D, Kessels MM, (2011) Let's go bananas: revisiting the endocytic BAR code. Embo J 30: 3501-3515.
11. Rao Y, Haucke V, (2011) Membrane shaping by the Bin/amphiphysin/Rvs (BAR) domain protein superfamily. Cell Mol Life Sci 68: 3983-3993.
12. Pant S, Sharma M, Patel K, Caplan S, Carr CM, et al. (2009) AMPH-1/Amphiphysin/Bin1 functions with RME-1/Ehd1 in endocytic recycling. Nat Cell Biol 11: 1399-1410.
13. Barbieri MA, Roberts RL, Mukhopadhyay A, Stahl PD, (1996) Rab5 regulates the dynamics of early endosome fusion. Biocell 20: 331-338.
14. Fukuda M, (2008) Regulation of secretory vesicle traffic by Rab small GTPases. Cell Mol Life Sci 65: 2801-2813.
15. Grosshans BL, Ortiz D, Novick P, (2006) Rabs and their effectors: achieving specificity in membrane traffic. Proc Natl Acad Sci U S A 103: 11821-11827.
16. Somsel Rodman J, Wandinger-Ness A, (2000) Rab GTPases coordinate endocytosis. J Cell Sci 113 Pt 2: 183-192.
17. Clague MJ, Urbe S, (2001) The interface of receptor trafficking and signalling. J Cell Sci 114: 3075-3081.
18. Navaroli DM, Bellve KD, Standley C, Lifshitz LM, Cardia J, et al. (2012) Rabenosyn-5 defines the fate of the transferrin receptor following clathrin-mediated endocytosis. Proc Natl Acad Sci U S A 109: E471-480.
19. Kajiho H, Saito K, Tsujita K, Kontani K, Araki Y, et al. (2003) RIN3: a novel Rab5 GEF interacting with amphiphysin II involved in the early endocytic pathway. J Cell Sci 116: 4159-4168.
20. Hu H, Bliss JM, Wang Y, Colicelli J, (2005) RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration. Curr Biol 15: 815-823.
21. Kong C, Su X, Chen PI, Stahl PD, (2007) RIN1 interacts with signal transducing adaptor molecule (STAM) and mediates epidermal growth factor receptor trafficking and degradation. J Biol Chem 282: 15294-15301.
22. Tomshine JC, Severson SR, Wigle DA, Sun Z, Beleford DA, et al. (2009) Cell proliferation and epidermal growth factor signaling in non-small cell lung adenocarcinoma cell lines are dependent on Rin1. J Biol Chem 284: 26331-26339.
23. Barbieri MA, Kong C, Chen PI, Horazdovsky BF, Stahl PD, (2003) The SRC homology 2 domain of Rin1 mediates its binding to the epidermal growth factor receptor and regulates receptor endocytosis. J Biol Chem 278: 32027-32036.
24. Hu H, Milstein M, Bliss JM, Thai M, Malhotra G, et al. (2008) Integration of TGFbeta and RAS Signaling Silences a RAB5 GEF and Enhances Growth Factor-DIrected Cell Migration. Mol Cell Biol 28: 1573-1583.
25. Hunker CM, Galvis A, Veisaga ML, Barbieri MA, (2006) Rin1 is a negative regulator of the IL3 receptor signal transduction pathways. Anticancer Res 26: 905-916.
26. Hunker CM, Giambini H, Galvis A, Hall J, Kruk I, et al. (2006) Rin1 regulates insulin receptor signal transduction pathways. Exp Cell Res 312: 1106-1118.
27. Deininger K, Eder M, Kramer ER, Zieglgansberger W, Dodt HU, et al. (2008) The Rab5 guanylate exchange factor Rin1 regulates endocytosis of the EphA4 receptor in mature excitatory neurons. Proc Natl Acad Sci U S A 105: 12539-12544.
28. Tall GG, Barbieri MA, Stahl PD, Horazdovsky BF, (2001) Ras-activated endocytosis is mediated by the Rab5 guanine nucleotide exchange activity of RIN1. Dev Cell 1: 73-82.
29. Kalesnikoff J, Rios EJ, Chen CC, Nakae S, Zabel BA, et al. (2006) RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells. Proc Natl Acad Sci U S A 103: 2659-2664.
30. Kalesnikoff J, Rios EJ, Chen CC, Alejandro Barbieri M, Tsai M, et al. (2007) Roles of RabGEF1/Rabex-5 domains in regulating Fc epsilon RI surface expression and Fc epsilon RI-dependent responses in mast cells. Blood 109: 5308-5317.
31. Zhu H, Liang Z, Li G, (2009) Rabex-5 is a Rab22 effector and mediates a Rab22-Rab5 signaling cascade in endocytosis. Mol Biol Cell 20: 4720-4729.
32. Horiuchi H, Lippe R, McBride HM, Rubino M, Woodman P, et al. (1997) A novel Rab5 GDP/GTP exchange factor complexed to Rabaptin-5 links nucleotide exchange to effector recruitment and function. Cell 90: 1149-1159.
33. Lee E, Marcucci M, Daniell L, Pypaert M, Weisz OA, et al. (2002) Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle. Science 297: 1193-1196.
34. Leprince C, Romero F, Cussac D, Vayssiere B, Berger R, et al. (1997) A new member of the amphiphysin family connecting endocytosis and signal transduction pathways. J Biol Chem 272: 15101-15105.
35. Ge K, Prendergast GC, (2000) Bin2, a functionally nonredundant member of the BAR adaptor gene family. Genomics 67: 210-220.
36. Hu H, Milstein M, Bliss JM, Thai M, Malhotra G, et al. (2008) Integration of transforming growth factor beta and RAS signaling silences a RAB5 guanine nucleotide exchange factor and enhances growth factor-directed cell migration. Mol Cell Biol 28: 1573-1583.
37. Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, et al. (2003) Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk Res 27: 677-682.
38. Dinneen JL, Ceresa BP, (2004) Continual expression of Rab5(Q79L) causes a ligand-independent EGFR internalization and diminishes EGFR activity. Traffic 5: 606-615.
39. Aichberger KJ, Mayerhofer M, Gleixner KV, Krauth MT, Gruze A, et al. (2007) Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412. Blood 109: 3031-3041.
40. Xu L, Lubkov V, Taylor LJ, Bar-Sagi D, (2010) Feedback regulation of Ras signaling by Rabex-5-mediated ubiquitination. Curr Biol 20: 1372-1377.
41. Prendergast GC, Muller AJ, Ramalingam A, Chang MY, (2009) BAR the door: cancer suppression by amphiphysin-like genes. Biochim Biophys Acta 1795: 25-36.
42. Kajiho H, Fukushima S, Kontani K, Katada T, (2012) RINL, guanine nucleotide exchange factor Rab5-subfamily, is involved in the EphA8-degradation pathway with odin. PLoS One 7: e30575.
43. Balaji K, Mooser CK, Janson CM, Bliss JM, Hojjat H, et al. (2012) RIN1 Orchestrates the Activation of RAB5 GTPases and ABL Tyrosine Kinases to Determine EGFR Fate. Journal of Cell Science (in press).
44. Kageyama-Yahara N, Suehiro Y, Yamamoto T, Kadowaki M, (2011) Rab5a regulates surface expression of FcepsilonRI and functional activation in mast cells. Biol Pharm Bull 34: 760-763.
45. Capdeville R, Buchdunger E, Zimmermann J, Matter A, (2002) Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov 1: 493-502.
46. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, et al. (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2: 561-566.
47. Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Tervahartiala P, et al. (2001) Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 344: 1052-1056.
48. Miyachi K, Ihara A, Hankins RW, Murai R, Maehiro S, et al. (2003) Efficacy of imatinib mesylate (STI571) treatment for a patient with rheumatoid arthritis developing chronic myelogenous leukemia. Clin Rheumatol 22: 329-332.
49. Nigrovic PA, Lee DM, (2005) Mast cells in inflammatory arthritis. Arthritis Res Ther 7: 1-11.
50. Jin Y, Lu Z, Cao K, Zhu Y, Chen Q, et al. (2010) The antitumor activity of homoharringtonine against human mast cells harboring the KIT D816V mutation. Mol Cancer Ther 9: 211-223.
51. Han L, Wong D, Dhaka A, Afar D, White M, et al. (1997) Protein binding and signaling properties of RIN1 suggest a unique effector function. Proc Natl Acad Sci U S A 94: 4954-4959.
52. Butterfield JH, Weiler D, Dewald G, Gleich GJ, (1988) Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 12: 345-355.
53. Laidlaw TM, Steinke JW, Tinana AM, Feng C, Xing W, et al. (2011) Characterization of a novel human mast cell line that responds to stem cell factor and expresses functional FcepsilonRI. J Allergy Clin Immunol 127: 815-822 e811-815.
54. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, et al. (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 95: 2509-2514.
55. Shayakhmetov DM, Papayannopoulou T, Stamatoyannopoulos G, Lieber A, (2000) Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector. J Virol 74: 2567-2583.